Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 225Actinium-armed antibody targeting CCR8+ regulatory T cells synergizes with immunotherapy to promote tumor rejection in syngeneic colorectal cancer models. | Front Immunol | 2025 | 41035646 | PubTator, text mining | PubMed |
| Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K. | J Funct Biomater | 2025 | 41003423 | PubTator, text mining | PubMed |
| CD45 + C1q + CCR8+ Cells as Emerging Indicators of Kidney Disease Severity and Progression Risk. | Nephrology (Carlton) | 2025 | 40955758 | PubTator, text mining | PubMed |
| Synthesis and Evaluation of Phenoxybenzylpiperidinyl Analogues as Agonists of the Chemokine Receptor CCR8. | Chem Biodivers | 2025 | 40924980 | PubTator, text mining | PubMed |
| Chemokine Receptor Profiles as Predictors of Survival and Early Progression in Follicular Lymphoma. | EJHaem | 2025 | 40896244 | PubTator, text mining | PubMed |
| T cell exhaustion‑related gene CD79B predicts prognosis, inhibits malignant progression and promotes tumor‑associated macrophage M1‑like polarization in lung adenocarcinoma. | Oncol Rep | 2025 | 40878933 | PubTator, text mining | PubMed |
| Unraveling the role of chemokines in cutaneous T-cell lymphoma: expression levels at different stages. | Front Immunol | 2025 | 40861461 | PubTator, text mining | PubMed |
| Pharmacological inhibition of the CCL2-CCR2 axis fails to reduce inflammation in a rat model of acute lung injury. | Sci Rep | 2025 | 40858671 | PubTator, text mining | PubMed |
| Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. | Signal Transduct Target Ther | 2025 | 40850976 | PubTator, text mining | PubMed |
| Coordinated changes in midkine expression and midkine-associated multiomic profile in glioma microenvironment. | Sci Rep | 2025 | 40835683 | PubTator, text mining | PubMed |
| The Streptomyces Metabolite Thiostrepton Inhibits Regulatory T Cell Differentiation and Function to Boost Antitumor Immune Responses. | Eur J Immunol | 2025 | 40820379 | PubTator, text mining | PubMed |
| FEN1 plays a key role in the transition from HSIL to CSCC. | Sci Rep | 2025 | 40820150 | PubTator, text mining | PubMed |
| Identification of IQGAP3 prognostic potential and involvement in immune cell infiltration in LUAD. | Eur J Med Res | 2025 | 40760442 | PubTator, text mining | PubMed |
| Predicting head and neck cancer response to radiotherapy with a chemokine-based model. | Sci Rep | 2025 | 40760079 | PubTator, text mining | PubMed |
| A dermis-on-a-chip model for compound screening. | Mater Today Bio | 2025 | 40740248 | PubTator, text mining | PubMed |
| Multi-omics analysis of zinc finger protein 683 as a prognostic biomarker for immune infiltration in clear cell renal cell carcinoma. | BMC Cancer | 2025 | 40730958 | PubTator, text mining | PubMed |
| DNA hypomethylation traits define human regulatory T cells in cutaneous tissue and identify their blood recirculating counterparts. | Nat Immunol | 2025 | 40670618 | PubTator, text mining | PubMed |
| Bispecific targeting of 4-1BB and CCR8 boosts antitumor immunity via Ti-Treg depletion and CD8+ activation. | iScience | 2025 | 40612509 | PubTator, text mining | PubMed |
| CCR8 Immunohistochemistry Highlights CCR8 as a Diagnostic and Therapeutic Biomarker in Cutaneous T-Cell Lymphoma. | J Invest Dermatol | 2025 | 40571156 | PubTator, text mining | PubMed |
| Insights on the role of the chemokine CCL8 in pathology. | Cell Signal | 2025 | 40541814 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=4